UCB SA (UCB) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.032x

Based on the latest financial reports, UCB SA (UCB) has a cash flow conversion efficiency ratio of 0.032x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€369.00 Million ≈ $431.40 Million USD) by net assets (€11.65 Billion ≈ $13.62 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see UCB company net worth for the company's overall valuation and market capitalisation.

UCB SA - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how UCB SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

UCB SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of UCB SA ranked by their cash flow conversion efficiency. Explore UCB SA (UCB) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
WEG S.A.
SA:WEGE3
0.066x
Adani Power Limited
NSE:ADANIPOWER
0.225x
ASM INTL N.V. NY/1 EO-04
F:AVSN
0.010x
Agilent Technologies Inc
NYSE:A
0.054x
Asia Vital Components Co Ltd
TW:3017
0.249x
Haleon plc
NYSE:HLN
0.055x
China CSSC Holdings Ltd
SHG:600150
0.014x
Adani Ports and Special Economic Zone Limited
NSE:ADANIPORTS
0.096x

Annual Cash Flow Conversion Efficiency for UCB SA (2000–2025)

The table below shows the annual cash flow conversion efficiency of UCB SA from 2000 to 2025. View UCB live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €10.87 Billion
≈ $12.70 Billion
€2.16 Billion
≈ $2.53 Billion
0.199x +60.72%
2024-12-31 €10.03 Billion
≈ $11.72 Billion
€1.24 Billion
≈ $1.45 Billion
0.124x +46.05%
2023-12-31 €8.97 Billion
≈ $10.49 Billion
€761.00 Million
≈ $889.69 Million
0.085x -31.32%
2022-12-31 €9.06 Billion
≈ $10.60 Billion
€1.12 Billion
≈ $1.31 Billion
0.123x -33.34%
2021-12-31 €8.39 Billion
≈ $9.80 Billion
€1.55 Billion
≈ $1.82 Billion
0.185x +24.58%
2020-12-31 €7.27 Billion
≈ $8.50 Billion
€1.08 Billion
≈ $1.26 Billion
0.149x +18.13%
2019-12-31 €7.01 Billion
≈ $8.19 Billion
€882.00 Million
≈ $1.03 Billion
0.126x -27.72%
2018-12-31 €6.25 Billion
≈ $7.31 Billion
€1.09 Billion
≈ $1.27 Billion
0.174x +7.73%
2017-12-31 €5.74 Billion
≈ $6.71 Billion
€927.00 Million
≈ $1.08 Billion
0.162x +107.29%
2016-12-31 €5.48 Billion
≈ $6.40 Billion
€427.00 Million
≈ $499.21 Million
0.078x +75.76%
2015-12-31 €5.55 Billion
≈ $6.48 Billion
€246.00 Million
≈ $287.60 Million
0.044x -60.71%
2014-12-31 €4.89 Billion
≈ $5.72 Billion
€552.00 Million
≈ $645.35 Million
0.113x +69.44%
2013-12-31 €4.32 Billion
≈ $5.05 Billion
€288.00 Million
≈ $336.70 Million
0.067x -13.81%
2012-12-31 €4.59 Billion
≈ $5.37 Billion
€355.00 Million
≈ $415.03 Million
0.077x +27.66%
2011-12-31 €4.82 Billion
≈ $5.64 Billion
€292.00 Million
≈ $341.38 Million
0.061x -45.06%
2010-12-31 €4.59 Billion
≈ $5.37 Billion
€506.00 Million
≈ $591.57 Million
0.110x +64.99%
2009-12-31 €4.42 Billion
≈ $5.16 Billion
€295.00 Million
≈ $344.89 Million
0.067x -26.70%
2008-12-31 €4.02 Billion
≈ $4.70 Billion
€366.00 Million
≈ $427.89 Million
0.091x -20.71%
2007-12-31 €4.26 Billion
≈ $4.99 Billion
€490.00 Million
≈ $572.86 Million
0.115x +71.05%
2006-12-31 €4.78 Billion
≈ $5.59 Billion
€321.00 Million
≈ $375.28 Million
0.067x -44.19%
2005-12-31 €2.41 Billion
≈ $2.82 Billion
€290.00 Million
≈ $339.04 Million
0.120x -67.06%
2004-12-31 €1.96 Billion
≈ $2.30 Billion
€718.17 Million
≈ $839.61 Million
0.365x -3.84%
2003-12-31 €1.78 Billion
≈ $2.09 Billion
€677.97 Million
≈ $792.61 Million
0.380x -0.34%
2002-12-31 €1.57 Billion
≈ $1.83 Billion
€596.97 Million
≈ $697.92 Million
0.381x +11.99%
2001-12-31 €1.39 Billion
≈ $1.63 Billion
€473.45 Million
≈ $553.51 Million
0.341x +18.59%
2000-12-31 €1.21 Billion
≈ $1.41 Billion
€346.26 Million
≈ $404.81 Million
0.287x --

About UCB SA

BR:UCB Belgium Biotechnology
Market Cap
$46.88 Billion
€40.10 Billion EUR
Market Cap Rank
#646 Global
#4 in Belgium
Share Price
€210.30
Change (1 day)
-0.14%
52-Week Range
€196.50 - €285.40
All Time High
€285.40
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, … Read more